Welcome to LookChem.com Sign In|Join Free
  • or
N-[3-methoxy-phenyl]-4-(2-chloro-4-pyridyl)-2-pyrimidineamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

229617-63-4

Post Buying Request

229617-63-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

229617-63-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 229617-63-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,9,6,1 and 7 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 229617-63:
(8*2)+(7*2)+(6*9)+(5*6)+(4*1)+(3*7)+(2*6)+(1*3)=154
154 % 10 = 4
So 229617-63-4 is a valid CAS Registry Number.

229617-63-4Downstream Products

229617-63-4Relevant academic research and scientific papers

Identification of pyrimidine derivatives as hSMG-1 inhibitors

Gopalsamy, Ariamala,Shi, Mengxiao,Bennett, Eric M.,Bard, Joel,Zhang, Wei-Guo,Yu, Ker

, p. 6636 - 6641,6 (2012/12/12)

hSMG-1 kinase plays a dual role in a highly conserved RNA surveillance pathway termed nonsense-mediated RNA decay (NMD) and in cellular genotoxic stress response. Since deregulation of cellular responses to stress contributes to tumor growth and resistance to chemotherapy, hSMG-1 is a potential target for cancer treatment. From our screening efforts, we have identified pyrimidine derivatives as hSMG-1 kinase inhibitors. We report structure-based optimization of this pan-kinase scaffold to improve its biochemical profile and overall kinome selectivity, including mTOR and CDK, to generate the first reported selective hSMG-1 tool compound.

CYCLIC COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

-

Page 20, (2010/02/08)

The invention provides a novel class of cyclic compounds, pharmaceutical compositions comprising such cyclic compounds and methods of using such compounds to treat or prevent diseases and disorders associated with cyclin-dependent kinases (CDKs) activity,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 229617-63-4